-
Blood clots launch investigation over J&J vaccine The Johnson & Johnson (J&J) COVID-19 vaccine is under investigation following the reports of rare (potentially dangerous) blood clots with leading pharmaceutical authorities recommending a delay in...
-
Pfizer moves to test COVID-19 vaccine for adolescents Pfizer announces promising results of the latest clinical study for the COVID-19 vaccine with 2,260 adolescent participants with 100% effective results on participants between the ages...
-
The Olympics Committee promises vaccines for participants All sporting events around the world are facing changes with growing concerns around the coronavirus (COVID-19) pandemic, especially the biggest international sporting event the Olympics. The International...
-
Johnson and Johnson await approval for distribution of vaccine Johnson & Johnson takes the next big step in production for its coronavirus (COVID-19) vaccine requesting emergency authorization for use from the FDA. This request...
-
J&J releases COVID-19 vaccine after testing against new virus variants Johnson & Johnson offers new data on their single-dose COVID-19 vaccine tested with the newly emerged virus variants. The J&J vaccine data shows promising...
-
Advisory panel recommend FDA approval of Modern COVID-19 vaccine The FDA released an analysis of the data for the Moderna COVID-19 vaccine that supports the approval of the vaccine for emergency use. The next...